WuXi PharmaTech reported first quarter 2013 financial results that exceeded guidance. Total revenues grew 11.7% year-over-year to $131.9 million, driven by 15.5% growth in China-based laboratory services and 9.6% growth in manufacturing services. Non-GAAP diluted EPS grew 7.5% to $0.35. WuXi reconfirmed its full-year 2013 guidance for revenue growth of 13-15% and non-GAAP EPS growth of 6-9%. WuXi expects continued double-digit revenue growth across most business units in 2013 and remains focused on controlling costs and returning cash to shareholders.
Hillenbrand provides a Q3 2017 earnings presentation covering their financial performance and outlook. Some key points:
- Revenue increased 7% to $396 million driven by strong demand for plastics projects and hydraulic fracturing equipment.
- Net income grew 7% to $33 million and adjusted EBITDA increased 8% to $72 million.
- Process Equipment Group revenue rose 12% while Batesville declined 2% due to higher rates of cremation.
- The company reaffirmed its full year 2017 guidance for 1-3% total revenue growth and adjusted EPS of $2.00-$2.10.
The corporate presentation discusses PFSweb's financial performance and outlook. It provides key metrics such as service fee equivalent revenue, which was $185.3 million in 2015 and is projected to be $225 million in 2016. Adjusted EBITDA was $20.7 million in 2015 and is estimated to be $22.5 million in 2016. The presentation also outlines PFSweb's business segments and global operations across major eCommerce platforms. It positions the company as the only global provider of end-to-end eCommerce solutions and discusses how strategic acquisitions have expanded its total addressable market.
Owens Corning presented information at investor events in June 2017. The presentation discussed Owens Corning's focus on shareholder value and provided an overview of the company's Q2 2017 performance. It summarized the company's three business segments and highlighted its improved portfolio, earnings, cash flow, and macroeconomic drivers. Owens Corning aims to invest in organic growth, pursue value-creating acquisitions, and return cash to shareholders.
The document provides an earnings presentation for the second quarter of 2013. It summarizes financial results including 9.2% revenue growth year-over-year led by 18.6% growth in China-based laboratory services. Gross margins and operating margins were in line with recent quarters. GAAP diluted EPS grew 45.5% and guidance for the full year was increased. The presentation discusses performance of business units and previews expected results for the third quarter.
The document provides guidance for Valeant Pharmaceuticals' 2015 financial outlook. It projects revenue of $9.2-9.3 billion, representing 14-15% growth over 2014. Cash EPS is projected at $10.10-10.40, a 21-25% increase. Adjusted cash flow from operations is projected to be over $3.1 billion, a 25%+ increase. The guidance assumes continued strong organic growth across business units and key product launches delivering over $500 million in revenues.
- ADP reported solid fiscal 2016 results with 7% revenue growth and earnings per share of $2.89, up 13% from fiscal 2015.
- For fiscal 2017, ADP expects revenue growth of 7-9% and earnings per share growth of 10-12%, driven by continued growth in Employer Services and PEO Services.
- ADP will continue focusing on upgrading clients to modern cloud solutions and aligning its service model to support its HCM strategy.
Bapcor reported strong results for FY2016 with revenue up 82.7% and EPS growth of 31%. The acquisition of ANA contributed significantly to revenue growth. Burson Trade and Autobarn also achieved solid same store sales growth. Bapcor's strategic focus remains on growing its brands and expanding its national footprint across all divisions.
Masco Corporation held its 7th Annual Global Industrials and Materials Summit on June 8, 2016. John Sznewajs, Masco's CFO, discussed the company's transformation initiatives, outlook, and strategies for growth. Key points include:
- Masco has implemented a new management team and business model focused on operational excellence, portfolio management, and capital allocation. This has created a less cyclical business.
- The transformation has delivered stable revenues and strong profitability growth. Masco is positioned to continue outperforming through strategies leveraging its leading brands.
- Masco expects to generate over $2 billion in free cash flow over the next three years, allowing for investment, debt pay
Hillenbrand provides a Q3 2017 earnings presentation covering their financial performance and outlook. Some key points:
- Revenue increased 7% to $396 million driven by strong demand for plastics projects and hydraulic fracturing equipment.
- Net income grew 7% to $33 million and adjusted EBITDA increased 8% to $72 million.
- Process Equipment Group revenue rose 12% while Batesville declined 2% due to higher rates of cremation.
- The company reaffirmed its full year 2017 guidance for 1-3% total revenue growth and adjusted EPS of $2.00-$2.10.
The corporate presentation discusses PFSweb's financial performance and outlook. It provides key metrics such as service fee equivalent revenue, which was $185.3 million in 2015 and is projected to be $225 million in 2016. Adjusted EBITDA was $20.7 million in 2015 and is estimated to be $22.5 million in 2016. The presentation also outlines PFSweb's business segments and global operations across major eCommerce platforms. It positions the company as the only global provider of end-to-end eCommerce solutions and discusses how strategic acquisitions have expanded its total addressable market.
Owens Corning presented information at investor events in June 2017. The presentation discussed Owens Corning's focus on shareholder value and provided an overview of the company's Q2 2017 performance. It summarized the company's three business segments and highlighted its improved portfolio, earnings, cash flow, and macroeconomic drivers. Owens Corning aims to invest in organic growth, pursue value-creating acquisitions, and return cash to shareholders.
The document provides an earnings presentation for the second quarter of 2013. It summarizes financial results including 9.2% revenue growth year-over-year led by 18.6% growth in China-based laboratory services. Gross margins and operating margins were in line with recent quarters. GAAP diluted EPS grew 45.5% and guidance for the full year was increased. The presentation discusses performance of business units and previews expected results for the third quarter.
The document provides guidance for Valeant Pharmaceuticals' 2015 financial outlook. It projects revenue of $9.2-9.3 billion, representing 14-15% growth over 2014. Cash EPS is projected at $10.10-10.40, a 21-25% increase. Adjusted cash flow from operations is projected to be over $3.1 billion, a 25%+ increase. The guidance assumes continued strong organic growth across business units and key product launches delivering over $500 million in revenues.
- ADP reported solid fiscal 2016 results with 7% revenue growth and earnings per share of $2.89, up 13% from fiscal 2015.
- For fiscal 2017, ADP expects revenue growth of 7-9% and earnings per share growth of 10-12%, driven by continued growth in Employer Services and PEO Services.
- ADP will continue focusing on upgrading clients to modern cloud solutions and aligning its service model to support its HCM strategy.
Bapcor reported strong results for FY2016 with revenue up 82.7% and EPS growth of 31%. The acquisition of ANA contributed significantly to revenue growth. Burson Trade and Autobarn also achieved solid same store sales growth. Bapcor's strategic focus remains on growing its brands and expanding its national footprint across all divisions.
Masco Corporation held its 7th Annual Global Industrials and Materials Summit on June 8, 2016. John Sznewajs, Masco's CFO, discussed the company's transformation initiatives, outlook, and strategies for growth. Key points include:
- Masco has implemented a new management team and business model focused on operational excellence, portfolio management, and capital allocation. This has created a less cyclical business.
- The transformation has delivered stable revenues and strong profitability growth. Masco is positioned to continue outperforming through strategies leveraging its leading brands.
- Masco expects to generate over $2 billion in free cash flow over the next three years, allowing for investment, debt pay
Markit reported financial results for Q4 and full year 2014 with revenue increasing 11.3% and 12.4%, respectively. Adjusted EBITDA grew 15% in Q4 and 15.9% for the full year. All business segments saw revenue growth in 2014, with Solutions growing the fastest at 31.7% followed by Processing at 7.4% and Information at 5.9%. Net debt was reduced by 36.3% through strong operating cash flow and capital expenditure control.
The document summarizes CNO Financial Group's 4Q13 financial and operating results. Key points include:
- Businesses continued performing well with sales, premium, and earnings growth.
- Returning value to shareholders while continuing on path to investment grade status.
- Completed an OCB long-term care reinsurance transaction that reduced LTC exposure by 12% and was accretive to earnings.
- Investments in distribution channels drove consolidated sales growth of 6% for 2013.
- 4Q and full year results showed strength in annuity margins, investment returns, and OCB performance.
- Capital and liquidity positions remained strong with deployable capital of $160 million.
Owens Corning presented information on its Q2 2017 performance focused on shareholder value. It operates three strong businesses: Insulation, Roofing, and Composites. The presentation discussed OC's investment thesis of having market leading businesses, improved portfolio performance and earnings, and attractive macroeconomic drivers. It also provided an overview of each business segment and their financial profiles.
- Masonite reported 3Q16 net sales of $489.6 million, up 3% from 3Q15. Adjusted EBITDA increased 29% to $65.1 million.
- North American residential sales grew 11% due to strength in both retail and wholesale channels. Adjusted EBITDA margin expanded 210 bps.
- Europe sales declined 11% from foreign exchange impacts, but adjusted EBITDA grew 34% driven by portfolio optimization and higher average selling prices.
- Architectural sales grew 3% and adjusted EBITDA margin increased 110 bps from price increases.
- The company remains focused on operational efficiencies, new product innovation, and digital strategies to support long-term growth
The document summarizes Ingersoll Rand's 2017 Investor & Analyst Day. It provides an overview of the company, highlights its strong and improving financial performance, and outlines its strategy and outlook for continued sustainable performance through 2020. Ingersoll Rand's businesses are well positioned due to its leading brands and market positions. The company's business operating system delivers results through a focus on sustainability, innovation, employee engagement and operational excellence.
Hansen Technologies reported strong financial results for FY2016 with 40% revenue growth to $149 million and 45% EBITDA growth to $45.4 million. Organic growth, the full-year impact of the TeleBilling acquisition, and high employee utilization drove results. For FY2017, Hansen expects 4-8% organic billing revenue growth and revenue between $165-175 million including contributions from recent acquisitions. The company also expects to maintain an EBITDA margin between 25-30%.
ADP reported solid financial results for fiscal 2017, with 6% revenue growth and 13% adjusted EPS growth. Revenue increased to $12.4 billion and adjusted EBIT grew 8% to $2.4 billion. New business bookings were softer due to strong prior year bookings from ACA-related sales. For fiscal 2018, ADP expects 5-7% revenue growth, adjusted EBIT margin expansion, and 2-4% growth in adjusted diluted EPS. ADP will continue investing in innovation, service, and sales while returning capital to shareholders through dividends and share repurchases.
The document provides supplemental financial schedules updating Q2 2017 results and year-to-date 2017 results as of October 6, 2017 to reflect the impact of a restatement of financial statements. Key impacts of the restatement include deferred revenue recognition in the US K-12 business and correction of a deferred tax asset valuation allowance. Metrics such as billings, adjusted EBITDA, revenue, and net income for various periods were restated. Additional schedules provide details on the accounting restatement impacts and updates to cash flow, working capital, and pre-publication investment amounts.
Altium held an investor presentation covering its full year performance for 2016. Key highlights included 17% revenue growth to $93.6 million, a 29.3% EBITDA margin, and reaching over $100 million in sales. Altium also increased the number of new Altium Designer licenses sold by 20% and subscribed seats grew by 11% to 31,134. The presentation discussed Altium's strategy to achieve PCB market leadership by 2020 through continued product upgrades, partnerships, and acquisitions.
Genworth MI Canada Inc. reported its financial results for the fourth quarter of 2013 on February 5, 2014. The company achieved solid earnings performance in 2013 with net operating income growing 3% year-over-year to $349 million and book value per share increasing 6%. For the fourth quarter, the company reported net operating income of $85 million, operating EPS of $0.90, and book value per share of $32.53. The company benefited from a low loss ratio driven by strong portfolio quality and favorable economic conditions. Looking ahead, the company expects a stable housing market and modest premium growth in 2014 while maintaining strong underwriting performance.
The document analyzes and compares the financial ratios of Nestle and Unilever for 2010 and 2009. Some key highlights:
- Nestle had stronger liquidity ratios, with higher current, quick, and cash ratios compared to Unilever.
- Unilever saw decreases in total debt and long-term debt ratios from 2009 to 2010, while ratios were generally higher than Nestle.
- Inventory and receivables turnover ratios improved for both companies from 2009 to 2010, though Nestle ratios were weaker.
- Asset and profitability ratios like ROA, ROE, and profit margin were higher for Unilever in 2010 compared to 2009 and Nestle.
So in summary
This document provides a summary of Nielsen's Q1 2017 earnings results. Key points include:
- Revenue was $1.53 billion, up 3.2% in constant currency. Watch segment revenue grew 11.1% driven by total audience and Gracenote. Buy segment revenue declined 3.7% with challenges in developed markets.
- Adjusted EBITDA was $422 million, up 4.7% in constant currency.
- Nielsen reiterated its full-year 2017 guidance.
Fourth Quarter and Year End 2014 Financial Results Investor CallSquareTwoFinancial
The company reported financial results for year-end 2014, with consolidated ERP of $655 million and adjusted EBITDA of $198 million. Returns in 2014 were lower than previous years due to competitive market conditions. However, actively managed portfolios maintained strength, with initial 12-month returns reflecting conservatism. Purchases in Q4 2014 totaled $29 million according to the company's long-term investment strategy of diversification.
This document provides an overview and financial results of GAM Holding AG for 2013. Key points include:
- Underlying net profit grew 30% to CHF 210 million, while IFRS net profit more than doubled to CHF 201 million.
- Average assets under management in investment management increased 4% contributing to higher management fees.
- Operating expenses grew 9% due to increased personnel costs, though the cost/income ratio improved.
- A dividend of CHF 0.65 per share is proposed, a 30% increase over the prior year.
The document introduces Standard Life Aberdeen's new key performance metric of adjusted profit before tax to replace previous metrics used by Standard Life and Aberdeen. Adjusted profit before tax excludes certain items to provide a measure of sustainable recurring profit. It also discusses presenting pro forma results and insights from modeling to understand trends in financial performance as the companies integrate.
The document is an investor presentation for Canadian Tire Corporation that provides an overview of the company and its various business segments. It discusses the company's strengths, growth plans, and financial highlights for its retail banners (Canadian Tire, FGL Sports, and Mark's), CT REIT, and Canadian Tire Bank. The presentation outlines strategies to strengthen its core retail businesses, engage younger customers, expand digital capabilities, and pursue growth opportunities across its brands and real estate portfolio.
Sysco is presenting at a consumer conference to discuss its strategic plan and financial objectives over the next three years. The plan focuses on growing gross profit through local case growth and margin improvement, reducing supply chain and administrative costs, and leveraging technology and people. Sysco has achieved $410 million in operating income improvements so far, is on track to meet EPS targets, and has a ROIC of 13.1%, demonstrating strong initial results toward its three-year goals.
TrueBlue is a large staffing and recruitment process outsourcing (RPO) provider in the United States that serves over 130,000 clients annually. Some key facts about the company include that it has over $2.7 billion in annual revenue and has experienced 27% growth and a 16% adjusted EBITDA CAGR over the past few years. TrueBlue also discusses its strategic priorities, which involve growing its managed services offerings and expanding further into global RPO and emerging markets through acquisitions.
The document provides an overview of a company's financial results for the six months ended 30 June 2013. Key points include:
- Profit before tax was $82.3 million, down from $112.9 million in the same period in 2012.
- Gross written premiums increased 5% to $1.066 billion.
- The combined ratio was 89%, down from 91% the prior year.
- Prior year reserve releases were $60.8 million.
Zep Inc. reported strong financial results for the fourth quarter and fiscal year 2013. In the fourth quarter, revenue grew 6% to $182.2 million, gross margins improved 130 basis points, adjusted EBITDA grew 8% to $17 million, and free cash flow grew by almost $27 million. For fiscal year 2013, revenue grew 5.5%, gross margins improved 110 basis points, adjusted EBITDA grew 6% to $57 million, and free cash flow increased $34 million to $38 million. Looking ahead, Zep expects continued cost reductions and efficiency initiatives to drive further margin expansion and debt reduction in fiscal year 2014.
Genworth MI Canada Inc. reported increased profitability in Q3 2013 compared to Q3 2012. Net operating income was up 12% to $91 million and operating EPS was up 15% to $0.94. Premiums written were $161 million, down 9% from last year due to slower housing activity. The loss ratio improved to 22% from 30% last year. The investment portfolio remains high quality at $5.3 billion with a pre-tax yield of 3.7%. The MCT ratio remains strong at 218% and the company repurchased $55 million in shares. Overall, the company demonstrated stable performance with improving underwriting results.
Shutterfly Earnings for 1Q 2014 released after market close today. Released in tandem with their conference call - which starts in about 20 minutes: http://www.media-server.com/m/p/o42tycb9
Looks like they beat by $0.05 and gave updated guidance more or less in-line with consensus. Note that Goldman upgraded the stock 2 weeks ago...
Markit reported financial results for Q4 and full year 2014 with revenue increasing 11.3% and 12.4%, respectively. Adjusted EBITDA grew 15% in Q4 and 15.9% for the full year. All business segments saw revenue growth in 2014, with Solutions growing the fastest at 31.7% followed by Processing at 7.4% and Information at 5.9%. Net debt was reduced by 36.3% through strong operating cash flow and capital expenditure control.
The document summarizes CNO Financial Group's 4Q13 financial and operating results. Key points include:
- Businesses continued performing well with sales, premium, and earnings growth.
- Returning value to shareholders while continuing on path to investment grade status.
- Completed an OCB long-term care reinsurance transaction that reduced LTC exposure by 12% and was accretive to earnings.
- Investments in distribution channels drove consolidated sales growth of 6% for 2013.
- 4Q and full year results showed strength in annuity margins, investment returns, and OCB performance.
- Capital and liquidity positions remained strong with deployable capital of $160 million.
Owens Corning presented information on its Q2 2017 performance focused on shareholder value. It operates three strong businesses: Insulation, Roofing, and Composites. The presentation discussed OC's investment thesis of having market leading businesses, improved portfolio performance and earnings, and attractive macroeconomic drivers. It also provided an overview of each business segment and their financial profiles.
- Masonite reported 3Q16 net sales of $489.6 million, up 3% from 3Q15. Adjusted EBITDA increased 29% to $65.1 million.
- North American residential sales grew 11% due to strength in both retail and wholesale channels. Adjusted EBITDA margin expanded 210 bps.
- Europe sales declined 11% from foreign exchange impacts, but adjusted EBITDA grew 34% driven by portfolio optimization and higher average selling prices.
- Architectural sales grew 3% and adjusted EBITDA margin increased 110 bps from price increases.
- The company remains focused on operational efficiencies, new product innovation, and digital strategies to support long-term growth
The document summarizes Ingersoll Rand's 2017 Investor & Analyst Day. It provides an overview of the company, highlights its strong and improving financial performance, and outlines its strategy and outlook for continued sustainable performance through 2020. Ingersoll Rand's businesses are well positioned due to its leading brands and market positions. The company's business operating system delivers results through a focus on sustainability, innovation, employee engagement and operational excellence.
Hansen Technologies reported strong financial results for FY2016 with 40% revenue growth to $149 million and 45% EBITDA growth to $45.4 million. Organic growth, the full-year impact of the TeleBilling acquisition, and high employee utilization drove results. For FY2017, Hansen expects 4-8% organic billing revenue growth and revenue between $165-175 million including contributions from recent acquisitions. The company also expects to maintain an EBITDA margin between 25-30%.
ADP reported solid financial results for fiscal 2017, with 6% revenue growth and 13% adjusted EPS growth. Revenue increased to $12.4 billion and adjusted EBIT grew 8% to $2.4 billion. New business bookings were softer due to strong prior year bookings from ACA-related sales. For fiscal 2018, ADP expects 5-7% revenue growth, adjusted EBIT margin expansion, and 2-4% growth in adjusted diluted EPS. ADP will continue investing in innovation, service, and sales while returning capital to shareholders through dividends and share repurchases.
The document provides supplemental financial schedules updating Q2 2017 results and year-to-date 2017 results as of October 6, 2017 to reflect the impact of a restatement of financial statements. Key impacts of the restatement include deferred revenue recognition in the US K-12 business and correction of a deferred tax asset valuation allowance. Metrics such as billings, adjusted EBITDA, revenue, and net income for various periods were restated. Additional schedules provide details on the accounting restatement impacts and updates to cash flow, working capital, and pre-publication investment amounts.
Altium held an investor presentation covering its full year performance for 2016. Key highlights included 17% revenue growth to $93.6 million, a 29.3% EBITDA margin, and reaching over $100 million in sales. Altium also increased the number of new Altium Designer licenses sold by 20% and subscribed seats grew by 11% to 31,134. The presentation discussed Altium's strategy to achieve PCB market leadership by 2020 through continued product upgrades, partnerships, and acquisitions.
Genworth MI Canada Inc. reported its financial results for the fourth quarter of 2013 on February 5, 2014. The company achieved solid earnings performance in 2013 with net operating income growing 3% year-over-year to $349 million and book value per share increasing 6%. For the fourth quarter, the company reported net operating income of $85 million, operating EPS of $0.90, and book value per share of $32.53. The company benefited from a low loss ratio driven by strong portfolio quality and favorable economic conditions. Looking ahead, the company expects a stable housing market and modest premium growth in 2014 while maintaining strong underwriting performance.
The document analyzes and compares the financial ratios of Nestle and Unilever for 2010 and 2009. Some key highlights:
- Nestle had stronger liquidity ratios, with higher current, quick, and cash ratios compared to Unilever.
- Unilever saw decreases in total debt and long-term debt ratios from 2009 to 2010, while ratios were generally higher than Nestle.
- Inventory and receivables turnover ratios improved for both companies from 2009 to 2010, though Nestle ratios were weaker.
- Asset and profitability ratios like ROA, ROE, and profit margin were higher for Unilever in 2010 compared to 2009 and Nestle.
So in summary
This document provides a summary of Nielsen's Q1 2017 earnings results. Key points include:
- Revenue was $1.53 billion, up 3.2% in constant currency. Watch segment revenue grew 11.1% driven by total audience and Gracenote. Buy segment revenue declined 3.7% with challenges in developed markets.
- Adjusted EBITDA was $422 million, up 4.7% in constant currency.
- Nielsen reiterated its full-year 2017 guidance.
Fourth Quarter and Year End 2014 Financial Results Investor CallSquareTwoFinancial
The company reported financial results for year-end 2014, with consolidated ERP of $655 million and adjusted EBITDA of $198 million. Returns in 2014 were lower than previous years due to competitive market conditions. However, actively managed portfolios maintained strength, with initial 12-month returns reflecting conservatism. Purchases in Q4 2014 totaled $29 million according to the company's long-term investment strategy of diversification.
This document provides an overview and financial results of GAM Holding AG for 2013. Key points include:
- Underlying net profit grew 30% to CHF 210 million, while IFRS net profit more than doubled to CHF 201 million.
- Average assets under management in investment management increased 4% contributing to higher management fees.
- Operating expenses grew 9% due to increased personnel costs, though the cost/income ratio improved.
- A dividend of CHF 0.65 per share is proposed, a 30% increase over the prior year.
The document introduces Standard Life Aberdeen's new key performance metric of adjusted profit before tax to replace previous metrics used by Standard Life and Aberdeen. Adjusted profit before tax excludes certain items to provide a measure of sustainable recurring profit. It also discusses presenting pro forma results and insights from modeling to understand trends in financial performance as the companies integrate.
The document is an investor presentation for Canadian Tire Corporation that provides an overview of the company and its various business segments. It discusses the company's strengths, growth plans, and financial highlights for its retail banners (Canadian Tire, FGL Sports, and Mark's), CT REIT, and Canadian Tire Bank. The presentation outlines strategies to strengthen its core retail businesses, engage younger customers, expand digital capabilities, and pursue growth opportunities across its brands and real estate portfolio.
Sysco is presenting at a consumer conference to discuss its strategic plan and financial objectives over the next three years. The plan focuses on growing gross profit through local case growth and margin improvement, reducing supply chain and administrative costs, and leveraging technology and people. Sysco has achieved $410 million in operating income improvements so far, is on track to meet EPS targets, and has a ROIC of 13.1%, demonstrating strong initial results toward its three-year goals.
TrueBlue is a large staffing and recruitment process outsourcing (RPO) provider in the United States that serves over 130,000 clients annually. Some key facts about the company include that it has over $2.7 billion in annual revenue and has experienced 27% growth and a 16% adjusted EBITDA CAGR over the past few years. TrueBlue also discusses its strategic priorities, which involve growing its managed services offerings and expanding further into global RPO and emerging markets through acquisitions.
The document provides an overview of a company's financial results for the six months ended 30 June 2013. Key points include:
- Profit before tax was $82.3 million, down from $112.9 million in the same period in 2012.
- Gross written premiums increased 5% to $1.066 billion.
- The combined ratio was 89%, down from 91% the prior year.
- Prior year reserve releases were $60.8 million.
Zep Inc. reported strong financial results for the fourth quarter and fiscal year 2013. In the fourth quarter, revenue grew 6% to $182.2 million, gross margins improved 130 basis points, adjusted EBITDA grew 8% to $17 million, and free cash flow grew by almost $27 million. For fiscal year 2013, revenue grew 5.5%, gross margins improved 110 basis points, adjusted EBITDA grew 6% to $57 million, and free cash flow increased $34 million to $38 million. Looking ahead, Zep expects continued cost reductions and efficiency initiatives to drive further margin expansion and debt reduction in fiscal year 2014.
Genworth MI Canada Inc. reported increased profitability in Q3 2013 compared to Q3 2012. Net operating income was up 12% to $91 million and operating EPS was up 15% to $0.94. Premiums written were $161 million, down 9% from last year due to slower housing activity. The loss ratio improved to 22% from 30% last year. The investment portfolio remains high quality at $5.3 billion with a pre-tax yield of 3.7%. The MCT ratio remains strong at 218% and the company repurchased $55 million in shares. Overall, the company demonstrated stable performance with improving underwriting results.
Shutterfly Earnings for 1Q 2014 released after market close today. Released in tandem with their conference call - which starts in about 20 minutes: http://www.media-server.com/m/p/o42tycb9
Looks like they beat by $0.05 and gave updated guidance more or less in-line with consensus. Note that Goldman upgraded the stock 2 weeks ago...
United Stationers reported financial results for the fourth quarter and full year of 2013. For Q4 2013, sales were down 1.6% to $1.2 billion compared to Q4 2012. Adjusted earnings per share increased 6% to $0.86 compared to $0.81 in Q4 2012. For the full year, sales were flat at $5.1 billion while adjusted earnings per share increased 17% to $3.29 compared to $2.82 in 2012. Gross margin rate improved for both the quarter and full year while adjusted operating expenses declined as a percentage of sales.
Hillenbrand provided a Q3 2016 earnings presentation covering consolidated and segment financial results. Key points include:
- Consolidated revenue decreased 7% to $371 million due to lower demand for capital equipment in the Process Equipment Group.
- GAAP EPS was $0.48, while adjusted EPS increased slightly to $0.53.
- Batesville revenue declined 3% but adjusted EBITDA margin improved 250 bps due to cost savings.
- Process Equipment Group revenue fell 9% but adjusted EBITDA margin rose 90 bps on pricing and acquisitions.
- Guidance for FY2016 expects organic revenue to decline 2-5% but adjusted EPS to reach $1.98
This document discusses Quintiles' third quarter 2014 earnings call. Some key points:
- Service revenue grew 13.8% and diluted adjusted earnings per share grew 22.6% compared to the third quarter of 2013.
- Net new business growth was 12.8% and the backlog was $10.75 billion.
- Guidance for full year 2014 expects service revenue growth between 9.2-10% and diluted adjusted EPS growth between 26.7-30.1%.
Go pro q2_2014_earnings_results_summary_slidesShaen PD
- GoPro reported revenue of $244.6 million for Q2 2014, up 38% from Q2 2013. Gross margin expanded 990 basis points to 42.2% year-over-year.
- Non-GAAP net income was $11.8 million for Q2 2014, up from a net loss of $3.2 million in Q2 2013.
- Units shipped increased 20.2% year-over-year to 854,000 in Q2 2014.
The document provides an investor update from McGraw-Hill Global Education Holdings for Q3 2015. It highlights that digital adjusted revenue grew 21% year-over-year driven by Connect sales. Total adjusted revenue declined slightly due to unfavorable foreign exchange rates impacting the international business. Adjusted EBITDA grew 6% year-over-year as digital revenue growth and cost savings offset continued investment in digital platforms. The company has significant liquidity and a net leverage ratio of 2.9x as of the end of Q3 2015.
Masco Corporation reported second quarter 2014 results with revenue growth of 5% and adjusted operating profit growth of 21%. Strong operating leverage led to a 140 basis point increase in adjusted operating margin. Cabinet sales declined 5% but initiatives are being executed to improve long-term performance. The outlook calls for continued execution of sales and profit initiatives despite lower industry growth.
- ClubCorp delivered strong Q3 2015 results, with revenue up 25% year-over-year to $255 million and adjusted EBITDA up 21% to $55 million.
- The company executed on its three-pronged growth strategy of organic growth, reinvention of existing clubs, and acquisitions. In Q3, it added elements to 19 clubs and had another 13 under construction. It also acquired 8 new clubs.
- For full-year 2015, ClubCorp tightened its adjusted EBITDA guidance to a range of $232-236 million, representing 18-20% growth over 2014, due to strong year-to-date performance and accelerated reinvention plans for acquired clubs.
- This document contains Quintiles' earnings presentation for the fourth quarter of 2014.
- Key highlights include 22.2% net new business growth, 9.3% constant currency service revenue growth, and 29.1% diluted adjusted earnings per share growth for Q4.
- For the full year 2014, Quintiles saw 10.1% constant currency service revenue growth, 31.1% diluted adjusted EPS growth, and $11.24 billion in diversified backlog.
1. CNO Financial reported financial and operating results for 1Q13 with earnings growth across its core business segments and higher operating EPS compared to 1Q12.
2. Investment income increased due to growth in invested assets and a targeted credit strategy, while underwriting margins remained strong.
3. Capital levels remained high with an RBC ratio of 366% and leverage of 19.5%, and the company deployed capital by repurchasing convertible debt.
Zichun Gao Professor Karen Accounting 1AIBM FInancial Stat.docxransayo
Zichun Gao Professor Karen Accounting 1A
IBM FInancial Statement Analysis
Financial Ratios 2019 2018 Formula
Current Ratio 1.02 1.29 CA/CL
Profit Margin 12.22% 12.35% Net Income/Total Revenue
Receiveables Turnover 9.80 10.71 Revenue/Average AR
Average Collection Period 36.72 33.62 365/Receiveables Turnover
Inventory Turnover 25.11 25.36 COST/Average Inventory
Days in Inventory 14.53 14.39 365/Inventory Turnover
Debts to Asset Ratio 0.86 0.86 Total Debts/Total Assets
IBM's days in inventory is around two weeks and this means that goods in the inventory
as efficnetly distributed and that there is a consitantly good inventory control for the
company.
The company's debts to assets ratio is the same for two years and this means that the
company has less debt than asset. However, it is still a relatively poor ratio because this
might show that there are potential problems for the company to generate sufficient
revenue.
The current ratio of the company has decreased over the year, and this means that the
company has less liquid assets to cover its short term liabilities. Since the ratio is
currently approaching 1, the company might be having liquidation problem.
The profit margin for IBM is very stable and it has been about 12% for two years. The
company is performing the profit-generating ability at an average level and it is having
an average profit margin in the industry.
The receiveables turnover is good for the company while between these two years, there
is a decline. As the company is collecting its accounts receiveables around 10 times per
year, the collection is frequent.
The company has been collecting money from customers on credit sales approximately
once every month, and the company usually has fast credit collection, which means that
the risk for credit sales is relatively low.
Inventory turnover measures how many times a company sells and replaces inventory
during a year and for IBM, the number of times is stable and it is constantly around 25.
This means that the company has an efficient control of its goods in the inventory.
Free Cash Flow 11.90 11.90 CF_Operation-Capital Expenditures
Return on Assets 0.06 0.08 Net Income/Total Assets
Asset Turnover 0.51 0.65 Revenue/Assets
Figures From Financial Statement
From Income Statement pg.68
Net Income 9431 9828
Total Revenue 77147 79591
Cost 40657 42655
From Consolidated Balance Sheet pg.70
Current Assets 38420 49146
Current Liabilities 37701 38227
Accounts Receiveables 7870 7432
Inventory 1619 1682
Total Assets 152186 123382
Total Liabilities 131202 106452
From Cash Flow Overview pg.59
Net Cash From Op 14.3 15.6
Capital expenditures 2.4 3.7
The company currently has 11.9 billion dollars free cash flow for two years and this is a
relatively high level of free cash flow. With the high free cash flow, the company can
have more oportunity to expand, invest in new projects, pay dividends, or invest the
money into Resea.
United Stationers Inc. reported financial results for the third quarter and first nine months of 2013. For Q3, net sales increased 2.1% to $1.3 billion and earnings per share increased 11% to $1.01. For the first nine months, adjusted earnings per share increased 20.9% to $2.43 on net sales of $3.9 billion, which was slightly higher than the same period in 2012. Cash flow from operations for the first nine months was $79.4 million.
PTC Announces Q1 Results; Provides Q2 and Updated FY’14 OutlookPTC
PTC reported financial results for its first fiscal quarter of 2014, with revenue up 1-2% year-over-year. Non-GAAP EPS was up 37% to $0.50. For Q2 2014, PTC estimates revenue of $320-330 million and non-GAAP EPS of $0.43-$0.48. For fiscal year 2014, PTC estimates revenue of $1.33-1.35 billion and raises non-GAAP EPS guidance to $2.03-$2.13.
20180509 sauc q1 2018 teleconference slides finaldrhincorporated
- Sales were $39.5 million in Q1 2018, down 10.8% from Q1 2017 due to reduced traffic from changes in promotional strategies and calendar shifts.
- Adjusted EBITDA was $5.1 million, or 12.9% of sales, in Q1 2018. Restaurant-level EBITDA was $6.9 million, or 17.4% of sales.
- Favorable commodity costs and reduced G&A expenses helped offset the impact of lower sales on profitability. The company generated $3.2 million in free cash flow for the quarter.
This document provides an overview and financial results for Genworth MI Canada Inc. for the second quarter of 2013. Some key highlights include:
- Net operating income increased 11% year-over-year to $88 million.
- Solid financial results including a loss ratio of 25% and book value per share of $31.32.
- Premiums written were $137 million for the quarter and the number of delinquencies declined 26% year-over-year.
- The company maintained a strong capital position with a minimum capital test ratio of 216%.
Nutanix reported strong revenue growth in Q2 FY2017, with total revenue of $182 million, up 77% year-over-year. Billings were $227 million, up 59% year-over-year. The company saw continued growth in customers, deferred revenue, and the Global 2000, demonstrating the expansion of its business. Nutanix provided non-GAAP financial measures and key performance indicators to supplement its GAAP reporting and measure business performance.
- Third quarter financial results for Hillenbrand, a global diversified industrial company, showed revenue declining 4% to $399 million but increasing 3% on a constant currency basis driven by higher volume in both business segments.
- Adjusted earnings per share decreased 10% to $0.52 per diluted share while adjusted EBITDA declined 6% and operating cash flow was $76 million through the first three quarters.
- The Process Equipment Group saw a 4% constant currency revenue increase and a 110 basis point expansion in adjusted EBITDA margin, while Batesville had a 2% revenue increase but a 120 basis point decline in adjusted gross margin.
Q2 2016 earnings call presentation final v2Hillenbrand_IR
Hillenbrand provides a Q2 2016 earnings presentation covering their consolidated and segment financial performance. Some key points:
- Consolidated revenue decreased 4% to $387 million due to an 8% decline in Batesville revenue, while adjusted EPS of $0.49 was in line with prior year.
- The Process Equipment Group saw 2% lower revenue but improved adjusted EBITDA margins. Batesville also improved adjusted EBITDA margins despite an 8% revenue decline.
- For fiscal year 2016, Hillenbrand expects total revenue to decline 2-4% on a constant currency basis and adjusted EPS in the range of $2.05 to $2.15.
Presentation des resultats financiers du deuxieme trimestre 2013 de Genworth ...genworth_financial
This document provides a summary of Genworth MI Canada Inc.'s second quarter 2013 results. Key highlights include an 11% increase in net operating income compared to Q2 2012, strong capital levels with a minimum capital test ratio of 216%, and continued improvement in delinquency rates across regions. New insurance written in 2013 has benefited from solid borrower credit quality and stable housing prices.
Similar to WuXi Pharma Tech First Quarter 2013 Earnings Presentation (20)
Presentation Clayton Valley, NevadaFrom Drilling to PEA in under 2 YearsCompany Spotlight
The document summarizes Cypress Development Corp's Clayton Valley lithium project in Nevada. Key points include:
- A Preliminary Economic Assessment shows promising economics including a 32.7% IRR and $1.45 billion NPV.
- Measured and indicated resources total 8.9 million tonnes LCE with additional inferred resources.
- The project has the potential for low-cost production due to favorable geology and metallurgy.
- Upcoming catalysts in 2019 include a metallurgical study and prefeasibility study to further de-risk the project.
Aben Resources has made a new high-grade gold discovery at its flagship Forrest Kerr project in BC's Golden Triangle region. The region is known for major gold deposits and saw $100 million in exploration spending in 2017. Recent improvements have made the Forrest Kerr project more accessible via new roads. Aben's technical team has reinterpreted historical data and identified additional exploration targets. The project covers over 23,000 hectares of prospective geology along the Forrest Kerr fault zone that is similar to other major deposits in the Golden Triangle.
Aben Resources has discovered high-grade gold zones at its Forrest Kerr project in British Columbia's Golden Triangle. The first hole of the 2018 drill program intersected four separate high-grade gold zones within 190 metres, including 331.0 g/t Au over 1.0 metre. Aben plans to expand drilling at the Boundary North Zone and test other gold anomalies identified through soil sampling. The company also holds the Justin project in Yukon and Chico project in Saskatchewan near recent discoveries.
Cypress Development Corp. owns lithium claims in Clayton Valley, Nevada near Albemarle's Silver Peak lithium mine. A preliminary economic assessment found the project could have a 32.7% IRR and $1.45 billion NPV. The project would extract lithium from claystone using leaching and have average annual production of 24,042 tonnes of lithium carbonate over 40 years. Capital costs are estimated at $482 million to build a 15,000 tonne per day operation.
The document discusses Aben Resources Ltd., a gold exploration company with projects in British Columbia's Golden Triangle region and other areas of Western Canada. It provides an overview of Aben's management team and directors, flagship Forrest Kerr project, recent drilling results showing new high-grade gold discoveries, and its strategy to advance exploration through 2018. The document also briefly outlines Aben's other projects including the Chico gold project in Saskatchewan and Justin gold project in Yukon.
Cypress Development Corp. owns the Clayton Valley lithium project in Nevada. Drilling in 2017 intersected lithium-bearing claystone averaging 921 ppm Li over 77 meters thick. A maiden resource estimate calculated 3.287 million tonnes of lithium carbonate equivalent in the indicated category and 2.916 million tonnes LCE in inferred. Metallurgical tests show the claystone is acid leachable and able to recover over 80% of the lithium. Cypress plans additional drilling, engineering studies, and permitting to advance the project towards production.
- Aben Resources has three highly prospective gold projects in Western Canada including its flagship Forrest Kerr Project in BC's Golden Triangle region, which had recent drilling success expanding the Boundary North Zone.
- Management has over 100 years of combined experience in Western Canada and a proven track record of success.
- The projects have significant historic work identifying high-grade gold and robust discovery potential remains.
Cypress Development Corp. owns the Clayton Valley lithium project in Nevada. Drilling in 2017 intersected lithium-bearing claystone averaging 921 ppm Li over 77 meters. A maiden resource estimate classified over 1.3 million tonnes of lithium carbonate equivalent as indicated and inferred. Metallurgical testing shows the claystone is leachable with over 80% lithium recovery. Cypress aims to advance the project with engineering studies and further drilling to define resources with the goal of becoming a domestic lithium producer for the growing battery market.
The document provides forward-looking statements and discusses risks associated with such statements. It notes that some statements may be deemed forward-looking and lists factors that could cause actual results to differ from forward-looking statements. The document also identifies the qualified person for the technical information as Cornell McDowell and provides Aben's trading symbols and recent share information.
The document provides an overview of Aben Resources Ltd., a mineral exploration company with gold projects in Western Canada. It summarizes Aben's three key projects - Forrest Kerr in BC's Golden Triangle region with recent drill results discovering the Boundary Zone, Chico in Saskatchewan near producing mines, and Justin in Yukon's White Gold district. It outlines the management team's expertise and provides company details like shares outstanding and trading symbols.
- Cypress Development Corp owns the Clayton Valley lithium project in Nevada located near Albemarle's Silver Peak lithium brine operation.
- Drilling in 2017 encountered lithium mineralization averaging 921 ppm Li over 77 meters in 14 holes drilled.
- Metallurgical tests show the claystone is acid leachable with over 80% lithium extraction possible.
- Cypress aims to define a resource estimate in 2018 and advance the project with feasibility studies to develop a lithium operation.
The document discusses forward-looking statements and provides disclaimers about them. It introduces the qualified person for the technical information presented. It also lists Aben's trading symbols and recent share information including price and market capitalization.
1) Cypress Development Corp owns the Clayton Valley lithium project located next to Albemarle's Silver Peak mine in Nevada. Drilling in 2017 intersected lithium-bearing claystone averaging over 900 ppm Li to a depth of over 100 meters.
2) A maiden resource estimate classified over 1.5 million tonnes of lithium carbonate equivalent as indicated and inferred. Metallurgical testing shows the claystone is acid leachable to extract over 80% of the lithium.
3) The project is located in a strategic location to supply the growing lithium-ion battery market in the US, with lithium demand accelerating due to the increased production of electric vehicles globally.
TerraX Minerals is a Canadian mineral exploration company focused on exploring and developing its 100% owned 772 square km Yellowknife City Gold project located adjacent to the city of Yellowknife, Northwest Territories. The project covers high-grade Archean gold districts and has had multiple high-grade gold discoveries. TerraX has a strong management team with experience discovering and developing gold deposits and low exploration costs due to the project's excellent infrastructure and year-round access near Yellowknife.
This document discusses forward-looking statements and provides information about Aben Resources Ltd., including its stock symbols, shares outstanding, recent share price, market capitalization, and three gold exploration projects in Western Canada. It summarizes the management team's experience and the company's investment highlights. Specifically, it owns the Forrest Kerr gold project in British Columbia's Golden Triangle region, which saw successful drilling results in 2017 that led to a new discovery called the North Boundary zone.
Cypress Development Corp owns lithium claystone deposits in Clayton Valley, Nevada near Albemarle's Silver Peak lithium mine. Drilling in 2017 encountered lithium mineralization averaging 921 ppm Li over 77 meters in 14 holes. Metallurgical tests show the claystone is acid leachable with up to 80% lithium extraction. Cypress plans additional drilling, process engineering, and a preliminary economic assessment in 2018 to advance the project. The company sees potential for the project given growing lithium demand from electric vehicles and batteries.
TerraX Minerals is a Canadian mineral exploration company focused on exploring its 100% owned 772 square km Yellowknife City Gold project located near Yellowknife, Northwest Territories. The project covers high-grade Archean gold districts with known deposits and past producers. TerraX has made multiple high-grade gold discoveries on the property and identified several high-priority targets for further exploration and drilling. The company has a strong management team with experience discovering and developing deposits in the region.
Cypress Development Corp owns lithium claystone deposits in Clayton Valley, Nevada that have the potential to be a significant lithium resource. Drilling in 2017 encountered mineralization averaging 921 ppm lithium over 77 meters thick in 14 drill holes. Metallurgical testing shows the claystone is acid leachable with up to 80% lithium extraction. Cypress plans additional drilling, metallurgical testing, and a preliminary economic assessment in 2018 to further define the resource potential.
Cypress Development Corp owns lithium claystone deposits in Clayton Valley, Nevada near Albemarle's Silver Peak lithium mine. Drilling in 2017 encountered mineralization averaging 921 ppm lithium over 77 meters thick in 14 drill holes. Metallurgical tests show the claystone is acid leachable with up to 80% lithium extraction. Cypress plans additional drilling, metallurgical testing, and a preliminary economic assessment in 2018 to evaluate the project's potential.
Cypress Development Corp is exploring for lithium resources in Clayton Valley, Nevada. Recent drilling has encountered lithium-bearing claystone up to 112 meters below surface, with grades averaging over 800 ppm lithium. Metallurgical testing indicates 80% of the lithium can be extracted using a weak sulfuric acid solution. Cypress plans additional drilling in 2018 and expects to publish a initial lithium resource estimate in Q1 2018 to advance the project towards a preliminary economic assessment. The project is located near existing lithium production and infrastructure to be a potential new supply of lithium for the growing battery market.
Navigating the world of forex trading can be challenging, especially for beginners. To help you make an informed decision, we have comprehensively compared the best forex brokers in India for 2024. This article, reviewed by Top Forex Brokers Review, will cover featured award winners, the best forex brokers, featured offers, the best copy trading platforms, the best forex brokers for beginners, the best MetaTrader brokers, and recently updated reviews. We will focus on FP Markets, Black Bull, EightCap, IC Markets, and Octa.
Starting a business is like embarking on an unpredictable adventure. It’s a journey filled with highs and lows, victories and defeats. But what if I told you that those setbacks and failures could be the very stepping stones that lead you to fortune? Let’s explore how resilience, adaptability, and strategic thinking can transform adversity into opportunity.
Part 2 Deep Dive: Navigating the 2024 Slowdownjeffkluth1
Introduction
The global retail industry has weathered numerous storms, with the financial crisis of 2008 serving as a poignant reminder of the sector's resilience and adaptability. However, as we navigate the complex landscape of 2024, retailers face a unique set of challenges that demand innovative strategies and a fundamental shift in mindset. This white paper contrasts the impact of the 2008 recession on the retail sector with the current headwinds retailers are grappling with, while offering a comprehensive roadmap for success in this new paradigm.
𝐔𝐧𝐯𝐞𝐢𝐥 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐄𝐧𝐞𝐫𝐠𝐲 𝐄𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲 𝐰𝐢𝐭𝐡 𝐍𝐄𝐖𝐍𝐓𝐈𝐃𝐄’𝐬 𝐋𝐚𝐭𝐞𝐬𝐭 𝐎𝐟𝐟𝐞𝐫𝐢𝐧𝐠𝐬
Explore the details in our newly released product manual, which showcases NEWNTIDE's advanced heat pump technologies. Delve into our energy-efficient and eco-friendly solutions tailored for diverse global markets.
The Genesis of BriansClub.cm Famous Dark WEb PlatformSabaaSudozai
BriansClub.cm, a famous platform on the dark web, has become one of the most infamous carding marketplaces, specializing in the sale of stolen credit card data.
Best Competitive Marble Pricing in Dubai - ☎ 9928909666Stone Art Hub
Stone Art Hub offers the best competitive Marble Pricing in Dubai, ensuring affordability without compromising quality. With a wide range of exquisite marble options to choose from, you can enhance your spaces with elegance and sophistication. For inquiries or orders, contact us at ☎ 9928909666. Experience luxury at unbeatable prices.
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...my Pandit
Explore the fascinating world of the Gemini Zodiac Sign. Discover the unique personality traits, key dates, and horoscope insights of Gemini individuals. Learn how their sociable, communicative nature and boundless curiosity make them the dynamic explorers of the zodiac. Dive into the duality of the Gemini sign and understand their intellectual and adventurous spirit.
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...APCO
The Radar reflects input from APCO’s teams located around the world. It distils a host of interconnected events and trends into insights to inform operational and strategic decisions. Issues covered in this edition include:
Ellen Burstyn: From Detroit Dreamer to Hollywood Legend | CIO Women MagazineCIOWomenMagazine
In this article, we will dive into the extraordinary life of Ellen Burstyn, where the curtains rise on a story that's far more attractive than any script.
Call8328958814 satta matka Kalyan result satta guessing➑➌➋➑➒➎➑➑➊➍
Satta Matka Kalyan Main Mumbai Fastest Results
Satta Matka ❋ Sattamatka ❋ New Mumbai Ratan Satta Matka ❋ Fast Matka ❋ Milan Market ❋ Kalyan Matka Results ❋ Satta Game ❋ Matka Game ❋ Satta Matka ❋ Kalyan Satta Matka ❋ Mumbai Main ❋ Online Matka Results ❋ Satta Matka Tips ❋ Milan Chart ❋ Satta Matka Boss❋ New Star Day ❋ Satta King ❋ Live Satta Matka Results ❋ Satta Matka Company ❋ Indian Matka ❋ Satta Matka 143❋ Kalyan Night Matka..
4 Benefits of Partnering with an OnlyFans Agency for Content Creators.pdfonlyfansmanagedau
In the competitive world of content creation, standing out and maximising revenue on platforms like OnlyFans can be challenging. This is where partnering with an OnlyFans agency can make a significant difference. Here are five key benefits for content creators considering this option:
How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....Lacey Max
“After being the most listed dog breed in the United States for 31
years in a row, the Labrador Retriever has dropped to second place
in the American Kennel Club's annual survey of the country's most
popular canines. The French Bulldog is the new top dog in the
United States as of 2022. The stylish puppy has ascended the
rankings in rapid time despite having health concerns and limited
color choices.”
Presentation by Herman Kienhuis (Curiosity VC) on Investing in AI for ABS Alu...Herman Kienhuis
Presentation by Herman Kienhuis (Curiosity VC) on developments in AI, the venture capital investment landscape and Curiosity VC's approach to investing, at the alumni event of Amsterdam Business School (University of Amsterdam) on June 13, 2024 in Amsterdam.
Discover innovative uses of Revit in urban planning and design, enhancing city landscapes with advanced architectural solutions. Understand how architectural firms are using Revit to transform how processes and outcomes within urban planning and design fields look. They are supplementing work and putting in value through speed and imagination that the architects and planners are placing into composing progressive urban areas that are not only colorful but also pragmatic.
2. 1
Cautionary Note Regarding Forward-Looking Statements
This presentation contains "forward-looking statements” within the meaning of the
Private Securities Litigation Reform Act of 1995. Forward-looking statements are
not historical facts, but instead are predictions about future events. Examples of
forward-looking statements in this presentation include statements about our
second-quarter and full-year 2013 guidance, the goals of our various service
offerings and the prospects of our strategic partnerships. Although we believe that
our predictions are reasonable, future events are inherently uncertain and our
forward-looking statements may turn out to be incorrect. Our forward-looking
statements are subject to risks relating to, among other things, our ability to
increase volume for our chemistry service offerings, to meet timelines for the
expansion of our biologics service offerings, to realize the anticipated benefits of
our strategic partnerships, to protect our clients’ intellectual property and to
compete effectively. Additional information about these and other relevant risks can
be found in our Annual Report on Form 20-F for the year ended December 31,
2012. The forward-looking statements in this presentation speak only on the date
that they are made, and we assume no obligation to update any forward-looking
statements except as required by law.
3. 2
Use of Non-GAAP and Pro-Forma Financial Measures
We have provided the first-quarter 2012 and 2013 gross profit, gross
margin, operating income, operating margin, net income, net margin, and
earnings per ADS on a non-GAAP basis, which excludes share-based
compensation expenses and the amortization and deferred tax impact of
acquired intangible assets. We believe both management and investors
benefit from referring to these non-GAAP financial measures in assessing
our financial performance and liquidity and when planning and forecasting
future periods. These non-GAAP operating measures are useful for
understanding and assessing underlying business performance and
operating trends. We expect to continue to provide net income and
earnings per ADS on a non-GAAP basis using a consistent method on a
quarterly basis.
You should not view non-GAAP results on a stand-alone basis or as a
substitute for results under GAAP, or as being comparable to results
reported or forecasted by other companies, and should refer to the
reconciliation of GAAP measures to non-GAAP measures for the indicated
periods attached hereto.
4. 3
Overview
We are achieving double-digit, broad-based revenue growth, led by
China-based Laboratory Services and research manufacturing
Commercial manufacturing is building a pipeline of products to
reaccelerate growth in 2014 and beyond
We are effectively controlling our costs with strategies such as our
Wuhan chemistry facility and our Lean Sigma programs
By continuing to control our costs, we expect to maintain flat year-
over-year margins throughout 2013
As a result of our revenue growth and progress on margins, we are
reconfirming our full-year 2013 revenue and EPS guidance
5. 4
Overview
We continue to invest in capabilities and capacity across our
business units to sustain strong revenue and earnings growth
Our free cash flow is growing substantially, and we plan to return
much of it to shareholders through share purchases
To leverage our partners’ knowledge and experience, we are entering
into strategic partnerships to create more long-term value, such as
our JVs with MedImmune for novel biologics development in China
and with PRA for clinical trial services in China
6. 5
First-Quarter 2013 Performance Versus Guidance
Actual Guidance
Total Revenues $131.9 million $129-131 million
GAAP Diluted EPS $0.30 $0.26-$0.27
NonGAAP Diluted EPS $0.35 $0.31-$0.32
We exceeded our revenue guidance for the quarter mainly due to
better than expected performance by Manufacturing Services
We exceeded our EPS guidance for the quarter as a result of better
revenues, improvements in operational efficiency, and a $1.2 million
mark-to-market gain on foreign exchange forward contracts
7. 6
First-Quarter 2013 Revenue Summary
(US$ in millions)
First Quarter
2013 2012 Δ
Total Net Revenue $131.9 $118.0 11.7%
China-Based Laboratory Services $74.5 $64.4 15.5%
U.S.-Based Laboratory Services $23.0 $22.2 3.8%
Total Laboratory Services $97.5 $86.6 12.5%
Manufacturing Services $34.4 $31.4 9.6%
8. 7
Total Net Revenues
(US$ in Millions)
1Q12 2Q12 3Q12 4Q12 1Q13
Manufacturing
Services
China-Based
Laboratory
Services
Revenue Performance by Service
U.S.-Based
Laboratory
Services
$118.0
22.2
64.4
31.4
$130.4
70.3
23.3
36.8
77.0
21.9
26.9
$125.8
81.5
22.3
21.9
$125.7
74.5
23.0
34.4
$131.9
Overall, the company achieved
record revenues and double-
digit year-over-year revenue
growth in the first quarter
China-based Laboratory
Services experienced its typical
sequential decline in first-
quarter revenues and strong
year-over-year growth
U.S.-based Laboratory Services
achieved steady, but modest
growth in a more mature
market
Manufacturing Services
benefited from strong
sequential growth in both
research and commercial
manufacturing
9. 8
First-Quarter 2013 GAAP Financial Summary
(US$ in millions)
First Quarter
2013 2012
%
Growth
Net Revenue $131.9 $118.0 11.7%
Gross Profit 47.4 41.9 13.2%
Gross Margin 36.0% 35.5%
Operating Income 23.0 20.6 11.4%
Operating Margin 17.4% 17.5%
Net Income 21.7 21.0 3.4%
Effective Tax Rate 20.8% 16.3%
Weighted Average ADS Outstanding—Diluted 71,915,069 74,543,632 (3.5%)
Diluted Net Earnings Per ADS 0.30 0.28 7.2%
10. 9
(US$ in Millions)
1Q12 2Q12 3Q12 4Q12 1Q13
Gross
Profit/
Margin
Revenues
Operating
Income/
Margin
GAAP Revenues/Gross Profit/Operating Income
$118.0
20.6
41.9 35.5%
17.5%
$130.4
46.5
23.8
35.7%
18.2%
$125.8
21.5
46.1 36.6%
17.0%
$125.7
23.6
48.8 38.8%
18.7% 23.0
47.4
$131.9
36.0%
17.4%
Aside from one-time
benefits in 4Q12,
1Q13 margins were
generally in line with
those of prior
quarters
We expect flat year-
over-year GAAP
gross margin and
operating margin in
2013
11. 10
First-Quarter 2013 Non-GAAP* Financial Summary
*Excludes the impact of share-based compensation expenses and amortization and the
deferred tax impact of acquired intangible assets in both periods
(US$ in millions)
First Quarter
2013 2012
%
Growth
Net Revenue $131.9 $118.0 11.7%
Gross Profit 48.6 43.5 11.6%
Gross Margin 36.8% 36.8%
Operating Income 26.7 24.3 9.8%
Operating Margin 20.2% 20.6%
Net Income 25.4 24.5 3.7%
Weighted Average ADS Outstanding—Diluted 71,915,069 74,543,632 (3.5%)
Effective Tax Rate 18.5% 14.9%
Diluted Net Earnings Per ADS 0.35 0.33 7.5%
12. 11
(US$ in Millions)
1Q12 2Q12 3Q12 4Q12 1Q13
Gross
Profit/
Margin
Revenues
Operating
Income/
Margin
Non-GAAP Revenues/Gross Profit/Operating Income
24.3
43.5
$118.0
36.8%
20.6%
$130.4
21.0%
36.8%48.0
27.4
$125.8
26.6
47.6 37.8%
21.2%
$125.7
50.0
27.4 21.8%
39.8%
$131.9
48.6
26.7
36.8%
20.2%
We also expect flat
year-over-year non-
GAAP gross margin
and operating margin
in 2013
13. 12
Factors Impacting First Quarter 2013 Diluted Earnings Per ADS
$0.28
$0.30
$.06
($.01)
($.02)
1Q12
Diluted EPS
1Q13
Diluted EPS
Foreign
Exchange
Business
Growth
Investment* Share
Purchases
Labor
Inflation
$.01
* Investment includes losses from biologics R&D, biologics manufacturing facilities, JVs with
MedImmune and risk sharing projects
$0.33
$0.35
GAAP
Non-GAAP
Non-GAAP
GAAP($.02)
14. 13
Capital Resources and Cash Flow
Cash and short-term investments of $265.7 million at March
31, 2013
Total debt of $67.9 million at March 31, 2013
Operating cash flow of $39.4 million for first-quarter 2013
Capital expenditures of $6.0 million for first-quarter 2013; we
continue to expect full-year capital expenditures of about
$60 million
15. 14
(US$ in Millions)
Capital
Expend-
itures
Operating
Cash
Flow
Free
Cash
Flow
Cash Flow and Share Purchases
$101.1
$131.0
$63.9
$37.1
$67.8
$63.2
Cash Flow Share Purchases
$67.0
$100.0
20122012 3/2013-
3/2015
Est.
2011
While making the
investments necessary
to sustain business
growth, we are
returning much of our
free cash flow to
investors
16. 15
We Reconfirm Full-Year 2013 Financial Guidance
Total revenues of $565-$575 million, up 13-15% year
over year
GAAP and non-GAAP gross margin and operating
margin comparable to those in 2012 (new guidance)
GAAP diluted earnings per ADS of $1.26-$1.30, up 6-9%
Non-GAAP diluted earnings per ADS of $1.49-$1.53, up
6-9%
Capital expenditures of about $60 million
17. 16
Second-Quarter 2013 Preview
Estimated total revenues of $138-$140 million
Estimated GAAP and Non-GAAP diluted earnings per ADS of
$0.34-$0.35 and $0.39-$0.40, respectively
Accelerating year-over-year revenue growth in the second half
of 2013 across several business units
18. 17
First-Quarter 2013 Revenue Distribution by Service Offering
1Q12 1Q13
Manufacturing
26.6%
Development**
9.0%
U.S. Lab
Services
17.5%
U.S. Lab
Services
18.8%
Medicinal
Chemistry
And Other
Discovery*
27.3%
Synthetic
Chemistry
18.3%
Manufacturing
26.1%
Development**
13.2%
Medicinal
Chemistry
And Other
Discovery*
26.0%
Synthetic
Chemistry
17.2%
*Includes Medicinal Chemistry, Biology, DMPK/ADME, Biological Reagents and others
**Includes Formulation, Analytical Development, Toxicology, Bioanalytical Services, Biologics,
Clinical, and Genomics
China-Based
Lab Services
19. 18
Synthetic Chemistry
This business (17% of total company revenue now) is
becoming commoditized, with competition from many Chinese
CROs causing pricing pressure
Our advantages of scale and experience will allow us to
achieve single-digit revenue growth in this business in 2013
Our Lean Sigma programs have resulted in significant
improvement in operating efficiency and cost savings
Synthetic chemistry work is increasingly being done at our new
Wuhan facility, which has relatively lower operating costs and
offers customers another pricing option
20. 19
Medicinal Chemistry and
Other Drug Discovery Services
We expect mid-teen revenue growth and stable profitability in
2013, driven by volume growth and improving productivity
New opportunities are available in medicinal chemistry
programs serving Chinese pharmaceutical clients
We expect substantial revenue and profit growth this year in
biology, where WuXi is building a leading technology platform
in oncology, infectious disease, CNS, and other areas
21. 20
Toxicology
Our toxicology business is growing well despite the
worldwide slump in this business
We are the #1 toxicology CRO in China
We more than doubled annual revenues in 2012 and are
targeting an increase of more than 40% in revenues in 2013;
more than 30% of revenues are from domestic Chinese
clients
This business is now profitable, and profitability will improve
with increasing capacity utilization
Our Suzhou site is currently at about 60% capacity; we
expect to reach optimum (~80-85%) capacity by year end and
will consider building out the remaining shell space within
the existing facility next year
22. 21
Biologics Services Overview
WuXi is the partner of choice for biologics services in China, as few CROs or
pharmaceutical companies have biologics facilities here
Chinese regulations require that biologics used in clinical trials either be approved in
other markets or manufactured in China
Our project portfolio is mostly novel molecules with some biosimilars from both
multinational and Chinese customers
We have built a highly capable team of about 350 people, including about 30 returnees
with US/EU industry experience
We made about $30 million in capital expenditures through the end of 2012, including
construction of discovery and development laboratories in Shanghai and a cGMP drug
substance manufacturing facility in WuXi in 2012, and we plan $16-$18 million more in
capital expenditures in 2013 to build out a fill/finish facility and purchase lab equipment
We plan to install 2,000 L bioreactors in the second half of 2013 that will enable us to
produce Phase 3 clinical trial materials
We continue to ramp up revenues with increasing numbers of projects; backlog totals
about $40 million as of the end of March; we are serving about 50 customers worldwide
23. 22
Strategic Partnerships in Drug Development
While WuXi will remain predominantly a CRO, we will help our
partners to develop and commercialize innovative products in
China
Some current medicinal chemistry projects earn bonuses for
success in return for lower FTE rates
Joint venture with MedImmune will develop and commercialize
MEDI5117 for treating rheumatoid arthritis and other
autoimmune diseases in China
Joint venture with PRA will offer a broad platform of Phase 1-4
clinical trial services in China, Hong Kong and Macau
Some biologics contracts include milestone payments and/or
single-digit royalties
24. 23
U.S.-Based Laboratory Services
First-half revenue growth is expected to be slower, due to lower
demand in biologics testing and difficult comparisons caused
by strong growth in the first half of 2012
Second-half growth is expected to be stronger
Profitability continues to improve
We continue to expect broad-based, high-single-digit revenue
growth, with stable margins, in this business in the long term
25. 24
Small Molecule Manufacturing Services
Overall small molecule manufacturing revenue to grow at mid-
teen rate in 2013, driven by strong growth in research
manufacturing
Commercial manufacturing revenue will be relatively flat year-
over-year in 2013 as we continue to diversify our portfolio
beyond one large product
We currently manufacture advanced intermediates for six
commercial products
We also manufacture supplies (intermediates and APIs) of
seven additional products currently in Phase 3, including some
with large commercial revenue potential for WuXi
26. 25
Building Our Capabilities Will Drive Growth
Continued revenue growth across China-based Laboratory
Services, driven by our ability to deliver high-quality services and
drug candidates for our customers
Increasing utilization of our integrated drug development services
for API manufacturing, IND-enabling toxicology studies and IND
filings with the China SFDA and global regulatory authorities
Continuing growth in Manufacturing Services driven by research
manufacturing and, beginning in 2014, a growing commercial-
manufacturing pipeline
Ramp-up of biologics drug discovery, development, and
manufacturing services
Expansion of our clinical development platform with the WuXi/PRA
joint venture
28. 27
1Q2013
(US$ in millions)
GAAP
Share-Based
Compensation
Expenses
Amortization of
Acquired Intangible
Assets and Deferred
Tax Impact Non-GAAP
Net revenues 131.9 131.9
Cost of revenues (84.5) 1.0 0.1 (83.4)
Selling & marketing expense (3.9) (3.9)
General & administrative expense (18.2) 2.6 (15.6)
Research & development expense (2.3) (2.3)
Other income/(exp.), net 4.4 4.4
Income tax expense (5.7) (5.7)
Net income 21.7 3.6 0.1 25.4
First-Quarter 2013 GAAP to Non-GAAP Reconciliation
29. 28
Share Count Information
(As of March 31, 2013)
ADS Shares
ADS issued and outstanding 70,961,529
Share options and equivalents granted and outstanding 2,986,228
ADS available for future grants under employee incentive plan 3,806,752
30. 29
ADS Shares for Earnings-per-ADS Calculation
Date Activities
Weighted
Average ADS
Shares
January 1, 2013 Ordinary share balance1
67,794,840
January 1, 2013 RSUs vested and not exercised 2,345,285
First Quarter 2013 Share options exercised and RSUs vested 229,413
First Quarter 2013 Share repurchase program (922)
March 31, 2013 ADSs outstanding – basic 70,368,616
March 31, 2013 Share options and equivalents 1,546,453
March 31, 2013 ADSs outstanding – diluted 71,915,069
1 542,358,719 ordinary shares, with each ADS representing eight ordinary shares